2|63|Public
5000|$|The {{business}} model {{of this company}} usually involves sending promotional email to invite attendees and speakers, at the same time, registration fee will be provided based on different levels of speakers in relevant fields. Unlike most congresses in which invited speakers' expenses are borne by the organizers, BIT life charges <b>speakers</b> <b>fees</b> for attendance as well as often inviting speakers that {{may not necessarily be}} key opinion leaders in the actual field. In addition, unlike traditional model of scientific congresses in which abstracts are usually submitted and peer reviewed before being accepted for presentation, speakers are guaranteed a speaking role as long as the attendance fees are paid.|$|E
30|$|EA lectured for MSD, Astellas, Gilead, and Alexion. His {{institution}} received {{research grants}} from Pfizer, Gilead, MSD, Cubist, and Fisher & Paykel; P.F. received grants from SIDACTION and the French ANRS (National Agency for AIDS Research) and honoraria and travel grants from ViiV Healthcare, Bristol-Myers Squibb, Janssen Cilag, Gilead Sciences, and MSD {{for participation in}} advisory board, educational programs, and international conferences; J.N. declares having received speaker fees and travel support from MSD; M.D. declares having received research grant from MSD, fund to organize educational meetings from Astellas, MSD, and Gilead, and <b>speakers</b> <b>fees</b> from Astellas, MSD, and Bristol-Myers Squibb. The authors declare {{that they have no}} competing interests.|$|E
30|$|Mona K Beyer {{received}} minor grants or <b>speaker’s</b> <b>fees</b> from Biogen Idec, Merck and Novartis. Hanne F. Harbo received minor grants or <b>speaker’s</b> <b>fees</b> from Biogen, Sanofi Genzyme, Merck, Novartis and Teva. The {{other authors}} do not report any disclosures.|$|R
30|$|FT and FK {{received}} traveling {{fees from}} Maquet; PM, DR, CL, HH, MH, GS, FL, RB and HW {{have nothing to}} disclose; RMM received traveling and <b>speaker</b> <b>fees</b> from Mitsubishi Pharma, Maquet and CSL Behring. PL received traveling <b>fees</b> and <b>speaker</b> <b>fees</b> from Novalung, Mitsubishi Pharma, Maquet and CSL Behring.|$|R
30|$|PCH, MS, BS and TGF are {{employees}} of Siemens Healthcare. JLW received <b>speaker’s</b> <b>fees</b> from Siemens Healthcare and GE Healthcare.|$|R
30|$|L.S.F. {{serves as}} an advisor to cmi-experts of Zurich, Switzerland and has {{received}} <b>speaker</b> <b>fees</b> from Siemens, Philips and Genzyme.|$|R
5000|$|Paid <b>speaker</b> <b>fees</b> {{to doctors}} who {{promoted}} {{the use of}} Xyrem for off-label purposes, such as insomnia and psychiatric disorders.|$|R
30|$|Dr. Kakumoto and Dr. Seo have {{received}} <b>speaker’s</b> <b>fee</b> from Edwards Lifesciences, {{but this is}} not relevant for the present report and has not influenced the manuscript.|$|R
30|$|L.S.F. is an {{associate}} of ZRN Grevenbroich and Dormagen, serves as an advisor to cmi-experts of Zurich, Switzerland and has received <b>speaker</b> <b>fees</b> from Siemens, Philips and Genzyme.|$|R
30|$|J.W. Renes and E.J. Regeer {{received}} <b>speaker’s</b> <b>fees</b> from AstraZeneca, Bristol-Myers Squibb, and Ely Lilly. A. W. Hoogendoorn reports no potential competing interests. W.A. Nolen {{has received}} {{grants from the}} Netherlands Organization for Health Research and Development, the European Union; has received honoraria/speaker’s fees from Lundbeck and Aristo Pharma, and has served as consultant for Daleco Pharma. R.W. Kupka received <b>speaker’s</b> <b>fees</b> for lectures on symposia sponsored by AstraZeneca, Bristol-Myers Squibb, Lundbeck, Sanofi, and Janssen. W.A. Nolen and R.W. Kupka were member of subsequent Dutch bipolar disorder guideline committees.|$|R
30|$|Dr. Frey has {{received}} grant/research support from Alternative Funding Plan Innovations Award, Brain and Behavior Research Foundation, Canadian Institutes of Health Research, Hamilton Health Sciences Foundation, J.P. Bickell Foundation, Ontario Brain Institute, Ontario Mental Health Foundation, Society for Women’s Health Research, Eli Lilly and Pfizer, and {{has received}} consulting and/or <b>speaker</b> <b>fees</b> from AstraZeneca, Bristol-Myers Squibb, Canadian Psychiatric Association, CANMAT, Lundbeck, Pfizer, Servier, and Sunovion. Dr. Sassi has received consulting and/or <b>speaker</b> <b>fees</b> from BMS and Jansen. Dr. Minuzzi, Dr. Streiner, and Ms. Cudney report no conflicts of interest.|$|R
30|$|Alain Cariou {{declares}} <b>speaker</b> <b>fees</b> {{and transport}} accommodation from Bard. Nicolas Deye declares <b>speaker</b> <b>fees,</b> transport accommodation, and research grants from BARD and ZOLL. Nicolas Deye {{was also the}} primary investigator of the ICEREA trial (partially granted by ALSIUS) and coordinator of the Cool Study (CSZ-Meditherm). Karim Asehnoune, Gérard Audibert, Astrid Botte, Olivier Brissaud, Guillaume Debaty, Sandrine Deltour, Nicolas Engrand, Gilles Francony, Bruno Levy, Cyrille Mathien, Philippe Meyer, Jean-Christophe Orban, Jean-François Payen, Sylvain Renolleau, Laure de Saint Blanquat, Lionel Velly, Bernard Vigue declare no competing interest with this manuscript.|$|R
5000|$|On March 5, 2009, Marin {{resigned}} {{her position}} {{as head of}} the CSCSA after inquiries by the Los Angeles Times into <b>speaker's</b> <b>fees</b> she had received and as the paper was preparing to publish a story concerning an ongoing investigation into her activities by the California Fair Political Practices Commission (CFPPC). A spokesman for Governor Schwarzenegger released a statement that Marin had violated administration policy that prohibits public officials from receiving <b>speaker's</b> <b>fees.</b> [...] Marin later fired back stating that [...] "administration officials knew what she was doing and never advised her to stop." ...|$|R
30|$|L.S.F. is an {{associate}} of ZRN Grevenbroich and Dormagen, and serves as an advisor to cmi-experts of Zurich, Switzerland. He has received <b>speaker</b> <b>fees</b> from Siemens, Philips and Genzyme.|$|R
30|$|Christophe VINSONNEAU {{declares}} {{funding and}} <b>speaker</b> <b>fees</b> from ASTUTE MEDICAL, transport accommodation from FRESENIUS MEDICAL and HOSPAL GAMBRO. Olivier JOANNES-BOYAU declares consulting fees from BAXTER, BBRAUN. Laurent MULLER declares <b>speaker</b> and reimbursement <b>fees</b> from FRESENIUS KABI and BBRAUN. Matthieu LEGRAND declares <b>speaker</b> <b>fees</b> from ALERE, funding fees from ASTUTE, BRAHMS, ABBOTT, GAMBRO-HOSPAL. Eric RONDEAU declares consulting or funding fees from NOVARTIS, ASTELLAS, ALEXION. Lionel VELLY declares consulting fees from NOVARTIS, HOSPAL-GAMBRO, FRESENIUS MEDICAL CARE, MSD. Fabien ARMANDO, Emmanuel CANET, Christophe CLEC’H, Jean-Michel CONSTANTIN, Michaël DARMON, Jacques DURANTEAU, Théophille GAILLOT, Arnaud GARNIER, Carole ICHAI, Laurent JACOB, Didier JOURNOIS, Laurent JUILLARD, Alexandre LAUTRETTE, Nicolas LEROLLE, Thomas RIMMELE, Bertrand SOUWEINE, Fabienne TAMION, Yannick WALRAVE declare no competing interest with this manuscript.|$|R
30|$|PCH, MS, BS and TGF are {{employees}} of Siemens Healthcare. JLW received <b>speaker’s</b> <b>fees</b> from Siemens Healthcare and GE Healthcare. The remaining authors declare {{that they have}} no competing interests.|$|R
50|$|Worldchanging was {{overseen by}} {{a board of}} directors, led by Worldchanging's chairman, the {{environmental}} photographer Edward Burtynsky until May 2010. Worldchanging was supported by grants, book sales, <b>speaker</b> <b>fees</b> and reader donations.|$|R
30|$|W. Nolen has {{received}} {{grants from the}} Netherlands Organisation for Health Research and Development, the European Union, received honoraria/speaker’s fees from Astra Zeneca, Lundbeck, and served as consultant for Daleco Pharma. M. Hillegers {{has received}} {{a grant from the}} Brain and Behaviour Research Foundation (NARSAD), the Netherlands Organisation for Health Research and Development, the European Union and <b>speaker</b> <b>fees</b> from Benecke and AstraZeneca. H. Drexhage has received grants from the Stanley Medical Research institute and the European Union and has received <b>speaker</b> <b>fees</b> from AstraZEneca. G. Snijders, L. de Witte, E. Mesman, S. Kemner, R. Brouwer, and R. Vonk do not have any competing interests to report.|$|R
30|$|Dr. Fletcher {{receives}} {{consulting fees}} for Medtronic Spine, Zimmer/Biomet Spine and Orthopaediatrics; <b>speaker’s</b> <b>fees</b> from Medtronic Spine and Zimmer/Biomet Spine; grant {{funding from the}} Harrison Foundation; and expert witness fees. No conflicts of interest are declared for the remaining authors.|$|R
5000|$|Daiichi Sankyo {{is being}} [...] "closely monitored" [...] after {{settling}} charges concerning payment of remuneration to physicians {{in the form}} of <b>speaker</b> <b>fees</b> as part of company's Physician Organization and Discussion program, in violation of the False Claims Act, an anti-kickback statute.|$|R
5000|$|... 3 News {{attended}} Nicholson's {{lecture and}} wrote, [...] "But despite a colourful performance from Ms Nicholson, this lot remains unconvinced." [...] Nicholson {{agreed to talk}} at the conference with the stipulation that the $500 <b>speakers</b> <b>fee</b> would be donated to a Women's Refuge." ...|$|R
40|$|DISCLOSURES: Maher has {{received}} grants, consulting <b>fees,</b> and <b>speaker</b> <b>fees</b> from GlaxoSmithKline and UCB and grants from Novartis. He has also received consulting <b>fees</b> and <b>speaker</b> <b>fees</b> from AstraZeneca, Bayer, Biogen Idec, Boehringer Ingelheim, Cipla, Lanthio, InterMune International AG (a wholly owned Roche subsidiary since 2014), F. Hoffmann-La Roche, Sanofi-Aventis, and Takeda. Maher {{is supported by}} a National Institute for Health Research Clinician Scientist Fellowship (NIHR Ref: CS:- 2013 - 13 - 017). Dejonckheere is an employee of F. Hoffmann-La Roche. Nathan {{has received}} consulting fees from Roche-Genentech and Boehringer Ingelheim. He is also on the speakers bureau for Roche-Genentech and Boehringer Ingelheim and has received research funding from both companies. All authors contributed equally to study concept and design, data collection and analysis, and manuscript preparation...|$|R
30|$|Braedius Medical, {{a company}} {{owned by a}} {{relative}} of Can Ince, has developed and designed a handheld microscope called CytoCam-IDF imaging. Can Ince has no financial relation with Braedius Medical of any sort; he never owned shares or received consultancy or <b>speaker</b> <b>fees</b> from Braedius Medical.|$|R
30|$|Dr. Van Regenmortel has {{received}} <b>speaker’s</b> <b>fees</b> from Baxter and is {{co-chair of the}} International Fluid Academy, a nonprofit organization promoting education on fluid management and hemodynamic monitoring that received sponsoring from the industry (www.fluid-academy.org). The other authors disclose {{that they do not}} have any potential competing interests.|$|R
40|$|Schering-Plough and a {{consultant}} for sanofi-aventis, Schering-Plough and The Medicines Co. Dr Cohen has received research ⁄ grant support and honoraria for <b>speaker’s</b> <b>fees,</b> from sanofi-aventis, Schering, Bristol-Myers Squibb and Merck. Re-use {{of this article is}} permitted in accordance with the Creative Commons Deed, Attribution 2. 5, which does not permit commercial exploitation...|$|R
30|$|A patent {{application}} was filed on 4 April 2011 by Ghent University with EM and Bert Maddens as inventors. The international {{patent application}} {{has been published}} as WO 2012 / 136548. EAJH received a <b>speaker’s</b> <b>fee</b> from Astute Medical and a research grant from Bellco. The remaining authors declare {{that they have no}} competing interests.|$|R
50|$|After {{speaking}} to the Rutgers University chapter of the American Meteorological Society in April 2003 concerning the Emergency Communications System in the United States, he toured their WeatherWatcher facility, which supplies media training for students within their meteorology program. He ultimately donated his <b>speaker's</b> <b>fee</b> to the WeatherWatcher program. His father attended the university previously in the 1950s.|$|R
30|$|RM has {{received}} research {{grants from the}} Stanley Medical Research Institute (non-profit organisation), and from Allergan, AstraZeneca, Janssen Ortho, Lundbeck, Otsuka, Pfizer, Purdue, and Shire. He {{has been part of}} advisory boards for, and received <b>speaker's</b> <b>fees</b> from, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Forest, Janssen Ortho, Johnson & Johnson, Lundbeck, Mitsubishi, Moksha 8, Otsuka, Pfizer, Purdue, Shire, Sunovion, and Takeda.|$|R
50|$|In 1989 he sued Trans World Airlines for $38,000 {{after his}} baggage arrived 70 minutes late at New York’s John F. Kennedy International Airport. Neely had flown from Seattle, Washington, to New York {{to appear on}} a {{television}} program, 20/20. In his suit, he sought $3,000 from TWA as a <b>speaker’s</b> <b>fee</b> because he informed fellow passengers about the delay. He {{settled out of court}} for $12,500.|$|R
30|$|US and MD are inventors on {{patents and}} patent {{applications}} covering therapeutic RNA vaccine technologies {{described in this}} article. CL declares the following competing interests: Advisory board for Roche, BMS, Novartis, Amgen, Leo, Pierre Fabre, and MSD. <b>Speakers</b> <b>fee</b> from Roche, BMS, Novartis, Amgen, Pierre Fabre, MSD, and Roche-Posay. Travel reimbursement from Roche, BMS, Novartis, Amgen, and Pierre Fabre. The other authors declare {{that they have no}} competing interests.|$|R
30|$|The Department of Nuclear Medicine {{holds an}} {{institutional}} Research Contract with GE Healthcare. Author IAB has received research grants and speaker honorarium from GE Healthcare and Swiss Life. Author IAB received speaker honorarium from Bayer Health Care and Astellas Pharma AG. Patrick Veit-Haibach received investigator-initiated study grants from Bayer Healthcare, Siemens Healthcare, Roche Pharmaceuticals, GE Healthcare, and <b>speaker’s</b> <b>fees</b> from GE Healthcare. Authors UJM, HWN, AB, JM, KNV, FdGB, and EEGWtV declare no conflict of interest.|$|R
40|$|Paille F, Martini H. Substance Abuse and Rehabilitation 2014; 5 : 87 – 94 On page 93, the Disclosure {{was listed}} as “The authors report no {{conflicts}} {{of interest in this}} work. ”, however it should have been “Francois Paille is consultant for Ethypharm and Lundbeck, received honoraria from Ethypharm and Lundbeck, <b>speaker</b> <b>fees</b> from Lundbeck and Merck Serono and travel grants from Lundbeck. Hervé Martini received travel grants from Reckitt-Benckiser and Lundbeck. ” Read the original articl...|$|R
3000|$|... (1) Michael Messerli {{received}} a research {{grant from the}} Iten-Kohaut Foundation, Switzerland. Stefano D’Aguanno is an employee of GE Healthcare. Gustav von Schulthess is a Consultant to GE Healthcare and a Co-Director of IDKD, an educational organization which receives funds from multiple companies. Martin Huellner received <b>speaker’s</b> <b>fees</b> from GE Healthcare. Apart from that, the other authors of this manuscript declare no relationships with any companies, whose products or services {{may be related to}} the subject matter of the article.|$|R
5000|$|Attempting {{to offset}} the controversy, UVSC invited {{conservative}} commentator Sean Hannity, scheduling his appearance a few days prior to Moore’s visit. Hannity waived his normal $100,000 <b>speakers</b> <b>fee,</b> but still demanded that UVSC cover his travel costs, which totaled $49,850, a figure which [...] "generally surprised" [...] UVSC officials when they received the bill. [...] Also featured in the film is prominent voice of the opposition, Kay Anderson, a local real estate mogul who offered UVSC $25,000 to cancel Moore’s appearance, and, when that failed, tried to sue the school for misuse of funds.|$|R
50|$|In 1855 Fee founded Berea College, {{the first}} {{college in the}} state that was interracial and coeducational. It began as a one-room schoolhouse, which also served as their local church. He modeled the school on Oberlin College of Ohio and hired some {{teachers}} from there as his school expanded. There was great interest in the college, as small as it was. In Governor Salmon P. Chase of Ohio attended its commencement ceremonies {{as one of the}} <b>speakers.</b> <b>Fee,</b> J.A.R. Rogers, who acted as principal, and other supporters drew up a constitution for the school, and pledged their own support with more than 100 acre of land for the college's campus.|$|R
5000|$|Following {{the concept}} of Seven American Deaths and Disasters, Kenneth Goldsmith read on March 13 The Body of Michael Brown, a text {{consisting}} of Michael Brown’s St. Louis County autopsy report rearranged as to end with the phrase [...] "The remaining male genitalia system is unremarkable". This caused strong negatives reactions not among the audience, but on Twitter and other social networks http://hyperallergic.com/190954/kenneth-goldsmith-remixes-michael-brown-autopsy-report-as-poetry/. Apparently, the recording of the performance was not made public by the Brown University (where the text was read) according to Goldsmith’s wish; he also claimed that [...] "my <b>speaker’s</b> <b>fee</b> from the Interrupt 3 event will be donated {{to the family of}} Michael Brown".|$|R
